Only Mesh Fixation With Glue of Ventral/Incisional Laparoscopic Hernia Repair
Launched by INSTITUT CATALA DE SALUT · Dec 13, 2023
Trial Information
Current as of November 07, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to fix hernias, which are bulges that can happen in the abdomen after surgery. Specifically, the trial is comparing two methods of attaching a special mesh (a type of material used to support the area where the hernia is) during laparoscopic surgery, which is a minimally invasive technique. One method uses a glue called GLUTACK-Glubran2®, while the other uses traditional mechanical staples. The main goal is to see if the glue method is just as good as the traditional method in preventing hernias from coming back within two years after surgery.
To participate in this trial, adults aged 18 to 80 who have a specific size hernia (between 4 to 8 cm) and a body mass index (BMI) under 35 are eligible. Participants will need to sign a consent form agreeing to take part in the study. If someone joins the trial, they can expect to undergo the laparoscopic hernia repair using one of the two methods being studied. It’s important to know that this trial is not yet recruiting participants, so there will be some time before anyone can sign up.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adults with a BMI lesser than 35 Kg/m2 undergoing an elective laparoscopic primary ventral or incisional hernia repair with a fascial transverse defect between 4-8 cm (W2 EHS) on anterior or lateral location (M1-M5 up to 10 cm of length or L1-3)
- • ASA grade from I-II
- • Informed consent signed
- Exclusion Criteria:
- • Patients less than 18 years and over 80 years of age.
- • Fascial transverse defect less than 4 cm and more than 8 cm.
- • Recurrent ventral or incisional hernia in the same place
- • Emergency surgery
- • Procedure involving concomitant surgeries (e.g. gastrointestinal, biliary or genitourinary surgery)
- • BMI greater than 35 Kg/m2
- • ASA III-IV
- • Pregnancy
- • Tobacco
About Institut Catala De Salut
The Institut Català de Salut (ICS) is a prominent public health organization in Catalonia, Spain, dedicated to providing high-quality healthcare services and advancing medical research. As a leading clinical trial sponsor, ICS integrates clinical practice with innovative research to enhance patient outcomes and contribute to the development of new therapeutic interventions. With a commitment to ethical standards and collaboration, ICS plays a pivotal role in the healthcare landscape by facilitating diverse clinical studies that address pressing health challenges and improve the overall well-being of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported